[TSX Therapeutics] Announcement of Key Resolutions from the 2026 Annual General Meeting

1. Date of the Annual General Meeting: 2026/05/25 2. Key Resolution 1, Earnings Distribution or Loss Compensation: Approved the company's 2025 loss compensation proposal. 3. Key Resolution 2, Articles of Incorporation Amendment: None. 4. Key Resolution 3, Business Report and Financial Statements: Approved the company's 2025 financial statements and business report. 5. Key Resolution 4, Election of Directors and Supervisors: None. 6. Key Resolution 5, Other Matters: Approved the proposal to lift non-compete restrictions for the company's directors (including independent directors). 7. Other Matters to be Noted: Approved the amendment to the company's "Procedures for Acquisition or Disposal of Assets." Approved the amendment to the company's "Procedures for Endorsement and Guarantee." Approved the amendment to the company's "Procedures for Election of Directors." Approved the amendment to the company's "Procedures for Lending Funds to Others." Approved the amendment to the company's "Rules of Procedure for Shareholders' Meetings."